Daniel R Chard
CEO, Chair at Medifast Inc (MED); Director at Medifast Inc (MED)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+4.6%
vs. S&P 500-11.5%
Beat the market0%
Paper profit on buys+$27K
Total bought / sold$179K / $226K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 30SEC | MEDMedifast Inc | Sell Plan | 9,545140,153 held (−6%) | $11.98 | $114K | -3.1% |
| Sep 30SEC | MEDMedifast Inc | Sell Plan | 9,544130,609 held (−7%) | $11.73 | $112K | -1.0% |
| Mar 27SEC | MEDMedifast Inc | Buy | 17,678new position | $10.11 | $179K | +14.8% |
- Sell
Director Daniel R Chard sold $114K of MED at $11.98 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Daniel R Chard sold $112K of MED at $11.73 — pre-scheduled 10b5-1 plan sale.
- Buy
CEO, Chair Daniel R Chard bought $179K of MED at $10.11 — first open-market purchase in our records; opens a new position.